Beijing Huaxia Qingyi Treatment Technology Co.,Ltd.
华夏清医
Beijing Huaxia Qingyi Treatment Technology Co.,Ltd.
Enterprise Software/SaaS
Huaxia Qingyi originated from Tsinghua University School of Medicine and focuses on the development and commercialization of innovative T-cell immunotherapy products. The company has partnered with several leading hospitals in the anti-infective field to launch multiple scientific research and…
Latest round: Angel (2019)
Source: ChinaBulls — chinabulls.com
Last updated 2019-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.